19-6364517-A-G
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM1PM2PM5PP3_Strong
The NM_006012.4(CLPP):c.433A>G(p.Thr145Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,558 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T145P) has been classified as Pathogenic.
Frequency
Consequence
NM_006012.4 missense
Scores
Clinical Significance
Conservation
Publications
- Perrault syndrome 3Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P
 - Perrault syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  Cov.: 30 
GnomAD2 exomes  AF:  0.00000406  AC: 1AN: 246318 AF XY:  0.00000746   show subpopulations 
GnomAD4 exome  AF:  6.85e-7  AC: 1AN: 1460558Hom.:  0  Cov.: 31 AF XY:  0.00000138  AC XY: 1AN XY: 726584 show subpopulations 
GnomAD4 genome  Cov.: 30 
ClinVar
Not reported inComputational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at